Published in J Biol Chem on June 25, 1999
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev (2000) 7.29
Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci U S A (2001) 3.24
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer (2003) 2.26
BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol (2001) 1.96
Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov (2014) 1.80
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med (2011) 1.79
Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med (2011) 1.68
Transcription-induced CAG repeat contraction in human cells is mediated in part by transcription-coupled nucleotide excision repair. Mol Cell Biol (2007) 1.61
BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II. Genes Dev (2005) 1.57
Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell (2013) 1.47
Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro. Proc Natl Acad Sci U S A (2002) 1.45
Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol (2010) 1.44
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression. PLoS One (2009) 1.36
A guide for functional analysis of BRCA1 variants of uncertain significance. Hum Mutat (2012) 1.34
BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol Cell Biol (2002) 1.28
Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci. Mol Cell Biol (2001) 1.17
Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability. Mol Cell Biol (2003) 1.16
Functional assays for BRCA1 and BRCA2. Int J Biochem Cell Biol (2006) 1.15
BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation. Proc Natl Acad Sci U S A (2012) 1.11
BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. J Mol Cell Biol (2011) 1.02
Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction. PLoS One (2008) 0.94
Homologous recombination is involved in transcription-coupled repair of UV damage in Saccharomyces cerevisiae. EMBO J (2005) 0.92
AKT regulates BRCA1 stability in response to hormone signaling. Mol Cell Endocrinol (2010) 0.91
A Molecular Toolkit to Visualize Native Protein Assemblies in the Context of Human Disease. Sci Rep (2015) 0.89
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy. Oncotarget (2013) 0.88
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) (2014) 0.88
A bioinformatics filtering strategy for identifying radiation response biomarker candidates. PLoS One (2012) 0.86
Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937. BMC Cancer (2006) 0.86
BRCA1 at a branch point. Proc Natl Acad Sci U S A (2001) 0.86
A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer. Oncotarget (2016) 0.84
BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels. Mol Cell Biol (2004) 0.83
Controversial BRCA1 allelotypes in commonly used breast cancer cell lines. Breast Cancer Res Treat (2009) 0.80
Detoxification: a novel function of BRCA1 in tumor suppression? Toxicol Sci (2011) 0.80
PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells. Biochem Pharmacol (2012) 0.80
Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC). Transl Lung Cancer Res (2013) 0.80
Emerging treatment options in the management of non-small cell lung cancer. Lung Cancer (Auckl) (2011) 0.78
Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line. BMC Cancer (2014) 0.77
Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer. Onco Targets Ther (2017) 0.77
BRCA1 Mutation: A Predictive Marker for Radiation Therapy? Int J Radiat Oncol Biol Phys (2015) 0.76
Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies. Breast Cancer Res (1999) 0.76
Pyrimidine base damage is increased in women with BRCA mutations. Cancer Lett (2013) 0.75
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer. BMC Cancer (2016) 0.75
The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control (2006) 10.62
Enzyme recruitment in evolution of new function. Annu Rev Microbiol (1976) 6.95
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology (2003) 3.97
Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell (1998) 3.86
Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci U S A (1986) 3.71
Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol (2000) 3.55
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer (1998) 3.12
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
Synthesis and characterization of phosphorescent cyclometalated iridium complexes. Inorg Chem (2001) 2.94
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health (2001) 2.70
Control of aromatic acid biosynthesis in Bacillus subtilis: sequenial feedback inhibition. J Bacteriol (1966) 2.65
Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell (1990) 2.63
Highly phosphorescent bis-cyclometalated iridium complexes: synthesis, photophysical characterization, and use in organic light emitting diodes. J Am Chem Soc (2001) 2.61
Ill-health retirement: national rates and updated guidance for occupational physicians. Occup Med (Lond) (2005) 2.53
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol (1996) 2.50
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA (2001) 2.49
Comparative control of a branch-point enzyme in microorganisms. J Bacteriol (1967) 2.39
The reliability and predictive validity of the Heaviness of Smoking Index and its two components: findings from the International Tobacco Control Four Country study. Nicotine Tob Res (2010) 2.34
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology (2000) 2.27
Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst (1998) 2.21
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21
Metabolic interlock. The dual function of a folate pathway gene as an extra-operonic gene of tryptophan biosynthesis. J Biol Chem (1972) 2.20
Hydroxylated quantum dots as luminescent probes for in situ hybridization. J Am Chem Soc (2001) 2.12
Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus. Lancet (1975) 2.06
Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science (1988) 2.05
Enzymological basis for herbicidal action of glyphosate. Plant Physiol (1982) 2.04
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci U S A (1990) 2.01
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer (1995) 2.01
Orthologs and paralogs - we need to get it right. Genome Biol (2001) 1.95
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis (2004) 1.92
Dual enzymatic routes to L-tyrosine and L-phenylalanine via pretyrosine in Pseudomonas aeruginosa. J Biol Chem (1977) 1.86
Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes. J Immunol (1988) 1.86
Regulatory enzymes of aromatic amino acid biosynthesis in Bacillus subtilis. I. Purification and properties of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase. J Biol Chem (1966) 1.82
The regulation of tryptophan biosynthesis in Pseudomonas aeruginosa. Mol Gen Genet (1973) 1.80
Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines. J Clin Invest (1986) 1.77
When and to what end do pathologists agree? J Natl Cancer Inst (1998) 1.76
Metabolic interlock. Regulatory interactions exerted between biochemical pathways. J Biol Chem (1969) 1.67
Chloroplasts of higher plants synthesize L-phenylalanine via L-arogenate. Proc Natl Acad Sci U S A (1986) 1.65
Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol (1995) 1.62
Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis. J Pediatr Hematol Oncol (1998) 1.59
Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med (1992) 1.58
Regulatory enzymes of aromatic amino acid biosynthesis in Bacillus subtilis. II. The enzymology of feedback inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase. J Biol Chem (1966) 1.58
Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem (1999) 1.57
Presentation of a new instrument: the diagnostic headache diary. Cephalalgia (1992) 1.57
Comparative regulation of isoenzymic 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetases in microorganisms. J Bacteriol (1968) 1.56
A biochemical basis for apparent abortive transformation in Bacillus subtilis. Genetics (1968) 1.55
Autonomic mechanisms in hemodynamic responses to isometric exercise. J Clin Invest (1974) 1.51
Differentially Regulated Isozymes of 3-Deoxy-d-arabino-Heptulosonate-7-Phosphate Synthase from Seedlings of Vigna radiata [L.] Wilczek. Plant Physiol (1985) 1.51
Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. J Biol Chem (1989) 1.51
Blue-green bacteria synthesise L-tyrosine by the pretyrosine pathway. Nature (1974) 1.51
The Two-Isozyme System of 3-Deoxy-d-arabino-Heptulosonate 7-Phosphate Synthase in Nicotiana silvestris and Other Higher Plants. Plant Physiol (1986) 1.49
Diversity in the routing and regulation of complex biochemical pathways as indicators of microbial relatedness. Crit Rev Microbiol (1982) 1.49
Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci (1999) 1.49
Metabolic interlock. The influence of histidine on tryptophan biosynthesis in Bacillus subtilis. J Biol Chem (1970) 1.48
BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci U S A (1999) 1.47
MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology (1993) 1.46
Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration. Am J Clin Pathol (2000) 1.45
Gout in the heart transplant recipient: physiologic puzzle and therapeutic challenge. Am J Med (1989) 1.42
Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma. Clin Chem (1997) 1.42
Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild. JAMA (1996) 1.42
Isolation and preparation of pretyrosine, accumulated as a dead-end metabolite by Neurospora crassa. J Bacteriol (1977) 1.41
Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol (2001) 1.41
The branch point metabolite for pyocyanine biosynthesis in Pseudomonas aeruginosa. J Gen Microbiol (1972) 1.40
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res (2001) 1.40
Direct correlation of external systolic time intervals with internal indices of left ventricular function in man. Circulation (1971) 1.40
Pseudomonas aeruginosa possesses homologues of mammalian phenylalanine hydroxylase and 4 alpha-carbinolamine dehydratase/DCoH as part of a three-component gene cluster. Proc Natl Acad Sci U S A (1994) 1.40
Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology (2006) 1.39
[Decreased pain threshold and tolerance in patients with chronic tension headache]. Ugeskr Laeger (1997) 1.38
Intracranial atherosclerotic plaque enhancement in patients with ischemic stroke. AJNR Am J Neuroradiol (2012) 1.34
Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J Biol Chem (1999) 1.34
Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol (1986) 1.32
Sound pressure correlates of the second heart sound. An intracardiac sound study. Circulation (1974) 1.32
The molecular aggregation of anthranilate synthase in Bacillus subtilis. Biochem Biophys Res Commun (1970) 1.31
Evolution of aromatic amino acid biosynthesis and application to the fine-tuned phylogenetic positioning of enteric bacteria. J Bacteriol (1990) 1.31
Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant (1996) 1.29
Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med (1982) 1.29
Enzymology of l-Tyrosine Biosynthesis in Mung Bean (Vigna radiata [L.] Wilczek). Plant Physiol (1979) 1.28
Intracellular roles of microbial aminotransferases: overlap enzymes across different biochemical pathways. Crit Rev Microbiol (1981) 1.27
Metabolic interlock. The role of the subordinate type of enzyme in the regulation of a complex pathway. J Biol Chem (1971) 1.27
The evolutionary pattern of aromatic amino acid biosynthesis and the emerging phylogeny of pseudomonad bacteria. J Mol Evol (1983) 1.26
Reported awareness of tobacco advertising and promotion in China compared to Thailand, Australia and the USA. Tob Control (2009) 1.26
Significance of altered carbon flow in aromatic amino acid synthesis: an approach to the isolation of regulatory mutants in Pseudomonas aeruginosa. J Bacteriol (1972) 1.24
A multispecific quintet of aromatic aminotransferases that overlap different biochemical pathways in Pseudomonas aeruginosa. J Biol Chem (1982) 1.24
Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg (1987) 1.23
Glyphosate Inhibition of 5-Enolpyruvylshikimate 3-Phosphate Synthase from Suspension-Cultured Cells of Nicotiana silvestris. Plant Physiol (1984) 1.23
Enzymological basis for growth inhibition by L-phenylalanine in the cyanobacterium Synechocystis sp. 29108. J Bacteriol (1980) 1.23
Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer (1996) 1.23
Documentation of auxotrophic mutation in blue-green bacteria: characterization of a tryptophan auxotroph in Agmenellum quadruplicatum. J Bacteriol (1972) 1.23
Evolutionary implications of different types of microbial enzymology for L-tyrosine biosynthesis. Nature (1975) 1.23
Comparative allostery of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase as an indicator of taxonomic relatedness in pseudomonad genera. J Bacteriol (1981) 1.23
Biochemical diversity for biosynthesis of aromatic amino acids among the cyanobacteria. J Bacteriol (1982) 1.22